Headache Disorders Completed Phase 1 / 2 Trials for Botulinum toxin type A (DB00083)

Also known as: Headache Disorder

IndicationStatusPhase
DBCOND0030525 (Headache Disorders)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02662972Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.Treatment